Skip to content

Design Therapeutics, Inc. DSGN Balance Sheet Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$12.77M-24.2%$16.86M+11.7%$15.09M-23.4%$19.7M+44.2%$13.67M-39.4%
$210.05M+3.5%$202.99M+6.3%$190.88M-2.9%$196.57M-9.0%$216.01M-3.1%
$227.05M+1.5%$223.78M+7.1%$209.03M-4.9%$219.79M-5.9%$233.64M-5.8%
$824K-16.0%$981K-11.1%$1.1M-12.2%$1.26M-8.6%$1.38M-2.3%
$230.44M+1.9%$226.2M+6.8%$211.77M-5.0%$222.89M-6.1%$237.48M-5.8%
$2.28M-1.6%$2.31M+20.9%$1.91M+88.8%$1.01M-68.1%$3.18M+45.5%
$10.19M-21.9%$13.06M+16.8%$11.17M+27.7%$8.75M+6.2%$8.24M-2.7%
$12.39M-9.6%$13.7M+13.7%$12.05M+22.3%$9.85M+3.1%$9.56M-4.4%
$6K0.0%$6K0.0%$6K0.0%$6K0.0%$6K0.0%
-$314.64M-5.9%-$297.01M-5.7%-$281.01M-6.4%-$264.01M-7.8%-$244.93M-7.8%
$218.05M+2.6%$212.5M+6.4%$199.72M-6.3%$213.04M-6.5%$227.92M-5.9%
$230.44M+1.9%$226.2M+6.8%$211.77M-5.0%$222.89M-6.1%$237.48M-5.8%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Design Therapeutics, Inc.'s total assets?
Design Therapeutics, Inc. (DSGN) holds $230.4M in total assets, down 3.0% year over year.
How much debt does Design Therapeutics, Inc. have?
Design Therapeutics, Inc. carries $2.7M in total debt against $218.1M of shareholders' equity, a debt-to-equity ratio of 0.01.
How much cash does Design Therapeutics, Inc. have?
Design Therapeutics, Inc. holds $12.8M in cash and equivalents.
Can Design Therapeutics, Inc. cover its short-term obligations?
Its current ratio is 22.28 — current assets exceed current liabilities.
Where does Design Therapeutics, Inc.'s balance sheet data come from?
Every line is extracted from Design Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.